Edition:
International

Michael Shields

Swiss will need COVID certificates to go to bars, restaurants

Sep 08 2021

ZURICH (Reuters) -People will need to show a COVID-status certificate to enter bars, restaurants and fitness centres in Switzerland from Monday, the government ordered, in a move to relieve pressure on hospitals that are struggling to cope with a fourth wave of infections.

Zurich Insurance boss wants carbon tax to punish polluters

Aug 12 2021

ZURICH, Aug 12 Zurich Insurance Chief Executive Mario Greco wants governments to levy a carbon tax and remove the incentive for socially irresponsible companies to maximise profits by polluting the environment, he told Reuters.

WHO-led trial to study three anti-inflammatory drugs for COVID-19 patients

Aug 11 2021

ZURICH The World Health Organization (WHO) said on Wednesday a clinical trial in 52 countries would study three anti-inflammatory drugs as potential treatments for COVID-19 patients.

Police clear climate activists from Zurich financial zone

Aug 09 2021

ZURICH (Reuters) -Police cleared climate activists from the heart of Zurich's financial district on Monday after dozens blocked entrances to offices of Switzerland's two biggest banks to protest against their financing of fossil fuel projects, authorities said.

Hard-won gains at risk as Delta variant spreads - WHO

Jul 30 2021

GENEVA The world is at risk of losing hard-won gains in fighting COVID-19 as the highly transmissible Delta variant spreads, but WHO-approved vaccines remain effective, the World Health Organization said on Friday. | Video

AC Immune lures BioNTech investors, buys Parkinson's vaccine candidate

Jul 27 2021

ZURICH AC Immune has gained a multi-million investment from main backers of German COVID-19 vaccine developer BioNTech while acquiring a possible Parkinson's disease vaccine, the Swiss biotech group said on Tuesday.

COVID-19 tests boost Roche sales but demand expected to weaken

Jul 22 2021

ZURICH (Reuters) -Swiss drugmaker Roche said on Thursday that strong demand for COVID-19 tests had helped it rebound from a weak start to the year, as it posted better-than-expected sales for the first half. | Video

Novartis profit tops expectations as pandemic impact ebbs

Jul 21 2021

ZURICH Swiss drugmaker Novartis beat second-quarter sales and profit expectations on Wednesday, while keeping its 2021 guidance unchanged, as disruption from the coronavirus pandemic waned. | Video

World News